Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Satoshi Katayama

Showing results (101-110 of 149) with videos related to

Pageof 15
Sort By:
Expert Review of Molecular Diagnostics|October 9, 2025
Urinary biomarkers for immunotherapy response in urothelial carcinoma: current status and future outlookShota Inoue, Marcin Miszczyk, Agata Suleja, et al.
Journal of Clinical Medicine|September 13, 2025
Risk Factors for Perioperative Urinary Tract Infection After Living Donor Kidney Transplantation Characterized by High Prevalence of Desensitization Therapy: A Single-Center AnalysisShingo Nishimura, Shota Inoue, Takanori Sekito, et al.
Japanese Journal of Clinical Oncology|December 26, 2025
Prognostic nutritional index predicts the prognostic impact of avelumab maintenance therapy in patients with advanced urothelial carcinoma: results from the Chu-shikoku Japan Urological ConsortiumHideo Fukuhara, Shingo Nishimura, Keita Kobayashi, et al.
Urologic Oncology|December 13, 2025
Oncological outcomes of deferred systemic therapy for patients with metastatic renal cell carcinoma: A systematic review and quantitative analysisIchiro Tsuboi, Pawel Rajwa, Marcin Miszczyk, et al.
Andrology|April 2, 2024
Trans men can achieve adequate muscular development through low-dose testosterone therapy: A long-term study on body composition changesYusuke Tominaga, Tomoko Kobayashi, Yuko Matsumoto, et al.
Clinical and Experimental Nephrology|May 26, 2026
Optimizing low-dose rituximab protocol for ABO-mismatched kidney transplantation: long-term outcomes in a single-center retrospective cohort studyTomoaki Yamanoi, Takanori Sekito, Moto Tokunaga, et al.
European Urology Focus|September 26, 2021
Choosing the Most Efficacious and Safe Oral Treatment for Idiopathic Overactive Bladder: A Systematic Review and Network Meta-analysisHadi Mostafaei, Hanieh Salehi-Pourmehr, Sandra Jilch, et al.
World Journal of Urology|June 18, 2021
Prognostic value of the systemic immune-inflammation index in non-muscle invasive bladder cancerSatoshi Katayama, Keiichiro Mori, Benjamin Pradere, et al.
World Journal of Urology|August 13, 2022
Impact of sex on outcomes after surgery for non-muscle-invasive and muscle-invasive bladder urothelial carcinoma: a systematic review and meta-analysisKeiichiro Mori, Takafumi Yanagisawa, Satoshi Katayama, et al.
International Journal of Urology : Official Journal of the Japanese Urological Association|April 3, 2022
Prognostic impact of insulin-like growth factor-I and its binding proteins, insulin-like growth factor-I binding protein-2 and -3, on adverse histopathological features and survival outcomes after radical cystectomyReza Sari Motlagh, Victor M Schuettfort, Keiichiro Mori, et al.
Pageof 15

Showing results (101-110 of 149) with videos related to

Sort By:
Pageof 15
Expert Review of Molecular Diagnostics|October 9, 2025
Urinary biomarkers for immunotherapy response in urothelial carcinoma: current status and future outlookShota Inoue, Marcin Miszczyk, Agata Suleja, et al.
Journal of Clinical Medicine|September 13, 2025
Risk Factors for Perioperative Urinary Tract Infection After Living Donor Kidney Transplantation Characterized by High Prevalence of Desensitization Therapy: A Single-Center AnalysisShingo Nishimura, Shota Inoue, Takanori Sekito, et al.
Japanese Journal of Clinical Oncology|December 26, 2025
Prognostic nutritional index predicts the prognostic impact of avelumab maintenance therapy in patients with advanced urothelial carcinoma: results from the Chu-shikoku Japan Urological ConsortiumHideo Fukuhara, Shingo Nishimura, Keita Kobayashi, et al.
Urologic Oncology|December 13, 2025
Oncological outcomes of deferred systemic therapy for patients with metastatic renal cell carcinoma: A systematic review and quantitative analysisIchiro Tsuboi, Pawel Rajwa, Marcin Miszczyk, et al.
Andrology|April 2, 2024
Trans men can achieve adequate muscular development through low-dose testosterone therapy: A long-term study on body composition changesYusuke Tominaga, Tomoko Kobayashi, Yuko Matsumoto, et al.
Clinical and Experimental Nephrology|May 26, 2026
Optimizing low-dose rituximab protocol for ABO-mismatched kidney transplantation: long-term outcomes in a single-center retrospective cohort studyTomoaki Yamanoi, Takanori Sekito, Moto Tokunaga, et al.
European Urology Focus|September 26, 2021
Choosing the Most Efficacious and Safe Oral Treatment for Idiopathic Overactive Bladder: A Systematic Review and Network Meta-analysisHadi Mostafaei, Hanieh Salehi-Pourmehr, Sandra Jilch, et al.
World Journal of Urology|June 18, 2021
Prognostic value of the systemic immune-inflammation index in non-muscle invasive bladder cancerSatoshi Katayama, Keiichiro Mori, Benjamin Pradere, et al.
World Journal of Urology|August 13, 2022
Impact of sex on outcomes after surgery for non-muscle-invasive and muscle-invasive bladder urothelial carcinoma: a systematic review and meta-analysisKeiichiro Mori, Takafumi Yanagisawa, Satoshi Katayama, et al.
International Journal of Urology : Official Journal of the Japanese Urological Association|April 3, 2022
Prognostic impact of insulin-like growth factor-I and its binding proteins, insulin-like growth factor-I binding protein-2 and -3, on adverse histopathological features and survival outcomes after radical cystectomyReza Sari Motlagh, Victor M Schuettfort, Keiichiro Mori, et al.
Pageof 15